Literature DB >> 9356496

Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

A J Cooper1, K R Sheu, J R Burke, O Onodera, W J Strittmatter, A D Roses, J P Blass.   

Abstract

Several adult-onset neurodegenerative diseases are caused by genes with expanded CAG triplet repeats within their coding regions and extended polyglutamine (Qn) domains within the expressed proteins. Generally, in clinically affected individuals n >/= 40. Glyceraldehyde 3-phosphate dehydrogenase binds tightly to four Qn disease proteins, but the significance of this interaction is unknown. We now report that purified glyceraldehyde 3-phosphate dehydrogenase is inactivated by tissue transglutaminase in the presence of glutathione S-transferase constructs containing a Qn domain of pathological length (n = 62 or 81). The dehydrogenase is less strongly inhibited by tissue transglutaminase in the presence of constructs containing shorter Qn domains (n = 0 or 10). Purified alpha-ketoglutarate dehydrogenase complex also is inactivated by tissue transglutaminase plus glutathione S-transferase constructs containing pathological-length Qn domains (n = 62 or 81). The results suggest that tissue transglutaminase-catalyzed covalent linkages involving the larger poly-Q domains may disrupt cerebral energy metabolism in CAG/Qn expansion diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356496      PMCID: PMC25053          DOI: 10.1073/pnas.94.23.12604

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Gain of glutamines, gain of function?

Authors:  D Housman
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

2.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

Authors:  J R Burke; J J Enghild; M E Martin; Y S Jou; R M Myers; A D Roses; J M Vance; W J Strittmatter
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

Review 3.  Aging, energy, and oxidative stress in neurodegenerative diseases.

Authors:  M F Beal
Journal:  Ann Neurol       Date:  1995-09       Impact factor: 10.422

4.  Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase.

Authors:  X J Li; A H Sharp; S H Li; T M Dawson; S H Snyder; C A Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue.

Authors:  S Zeitlin; J P Liu; D L Chapman; V E Papaioannou; A Efstratiadis
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

6.  Stimulation of glyceraldehyde-3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine-activated endothelium.

Authors:  J Bereta; M Bereta
Journal:  Biochem Biophys Res Commun       Date:  1995-12-05       Impact factor: 3.575

7.  Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.

Authors:  K Stott; J M Blackburn; P J Butler; M Perutz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein.

Authors:  Y S Jou; R M Myers
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

9.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

Authors:  C A Gutekunst; A I Levey; C J Heilman; W L Whaley; H Yi; N R Nash; H D Rees; J J Madden; S M Hersch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells.

Authors:  A R Robbins; R D Ward; C Oliver
Journal:  J Cell Biol       Date:  1995-09       Impact factor: 10.539

View more
  22 in total

1.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 2.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

3.  Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.

Authors:  Margherita Ruoppolo; Stefania Orrù; Simona Francese; Ivana Caputo; Carla Esposito
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

4.  The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction.

Authors:  Jee-Yeon Lee; Yeon-Ju Lee; Hye-Yoon Jeon; Eun-Taek Han; Won Sun Park; Seok-Ho Hong; Young-Myeong Kim; Kwon-Soo Ha
Journal:  FASEB J       Date:  2019-08-28       Impact factor: 5.191

5.  Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Stefania Orru; Margherita Ruoppolo; Simona Francese; Luigi Vitagliano; Gennaro Marino; Carla Esposito
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

Review 6.  The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration.

Authors:  Gary E Gibson; John P Blass; M Flint Beal; Victoria Bunik
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

7.  BMP2 cross-linked by transglutaminase 2 to collagen-plla scaffold promotes osteogenic differentiation in mesenchymal stem cells.

Authors:  Kelly E Beazley; Maria Nurminskaya
Journal:  Biotechnol Lett       Date:  2014-06-15       Impact factor: 2.461

Review 8.  Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

Authors:  Gary E Gibson; Anatoly Starkov; John P Blass; Rajiv R Ratan; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2009-08-26

9.  Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?

Authors:  A J Cooper; K F Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Age (Omaha)       Date:  1998-01

Review 10.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.